Cargando…
Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol
AIMS: Heart failure (HF) is associated with many hospital admissions and relatively high mortality, rates decreasing with administration of beta‐blockers (BBs), angiotensin‐converting‐enzyme inhibitors, angiotensin II receptor blockers, and mineralocorticoid receptor antagonists. The effect is dose...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695164/ https://www.ncbi.nlm.nih.gov/pubmed/29154427 http://dx.doi.org/10.1002/ehf2.12152 |
_version_ | 1783280263727415296 |
---|---|
author | Oyanguren, Juana García‐Garrido, LLuisa Nebot Margalef, Magdalena Lekuona, Iñaki Comin‐Colet, Josep Manito, Nicolás Roure, Julia Ruiz Rodriguez, Pilar Enjuanes, Cristina Latorre, Pedro Torcal Laguna, Jesús García‐Gutiérrez, Susana |
author_facet | Oyanguren, Juana García‐Garrido, LLuisa Nebot Margalef, Magdalena Lekuona, Iñaki Comin‐Colet, Josep Manito, Nicolás Roure, Julia Ruiz Rodriguez, Pilar Enjuanes, Cristina Latorre, Pedro Torcal Laguna, Jesús García‐Gutiérrez, Susana |
author_sort | Oyanguren, Juana |
collection | PubMed |
description | AIMS: Heart failure (HF) is associated with many hospital admissions and relatively high mortality, rates decreasing with administration of beta‐blockers (BBs), angiotensin‐converting‐enzyme inhibitors, angiotensin II receptor blockers, and mineralocorticoid receptor antagonists. The effect is dose dependent, suboptimal doses being common in clinical practice. The 2012 European guidelines recommend close monitoring and dose titration by HF nurses. Our main aim is to compare BB doses achieved by patients after 4 months in intervention (HF nurse‐managed) and control (cardiologist‐managed) groups. Secondary aims include comparing doses of the other aforementioned drugs achieved after 4 months, adverse events, and outcomes at 6 months in the two groups. METHODS: We have designed a multicentre (20 hospitals) non‐inferiority randomized controlled trial, including patients with new‐onset HF, left ventricular ejection fraction ≤40%, and New York Heart Association class II–III, with no contraindications to BBs. We will also conduct qualitative analysis to explore potential barriers to and facilitators of dose titration by HF nurses. In the intervention group, HF nurses will implement titration as prescribed by cardiologists, following a protocol. In controls, cardiologists will both prescribe and titrate doses. The study variables are doses of each of the drugs after 4 months relative to the target dose (%), New York Heart Association class, left ventricular ejection fraction, N‐terminal pro B‐type natriuretic peptide levels, 6 min walk distance, comorbidities, renal function, readmissions, mortality, quality of life, and psychosocial characteristics. CONCLUSIONS: The trial seeks to assess whether titration by HF nurses of drugs recommended in practice guidelines is safe and not inferior to direct management by cardiologists. The results could have an impact on clinical practice. |
format | Online Article Text |
id | pubmed-5695164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56951642018-02-14 Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol Oyanguren, Juana García‐Garrido, LLuisa Nebot Margalef, Magdalena Lekuona, Iñaki Comin‐Colet, Josep Manito, Nicolás Roure, Julia Ruiz Rodriguez, Pilar Enjuanes, Cristina Latorre, Pedro Torcal Laguna, Jesús García‐Gutiérrez, Susana ESC Heart Fail Original Research Articles AIMS: Heart failure (HF) is associated with many hospital admissions and relatively high mortality, rates decreasing with administration of beta‐blockers (BBs), angiotensin‐converting‐enzyme inhibitors, angiotensin II receptor blockers, and mineralocorticoid receptor antagonists. The effect is dose dependent, suboptimal doses being common in clinical practice. The 2012 European guidelines recommend close monitoring and dose titration by HF nurses. Our main aim is to compare BB doses achieved by patients after 4 months in intervention (HF nurse‐managed) and control (cardiologist‐managed) groups. Secondary aims include comparing doses of the other aforementioned drugs achieved after 4 months, adverse events, and outcomes at 6 months in the two groups. METHODS: We have designed a multicentre (20 hospitals) non‐inferiority randomized controlled trial, including patients with new‐onset HF, left ventricular ejection fraction ≤40%, and New York Heart Association class II–III, with no contraindications to BBs. We will also conduct qualitative analysis to explore potential barriers to and facilitators of dose titration by HF nurses. In the intervention group, HF nurses will implement titration as prescribed by cardiologists, following a protocol. In controls, cardiologists will both prescribe and titrate doses. The study variables are doses of each of the drugs after 4 months relative to the target dose (%), New York Heart Association class, left ventricular ejection fraction, N‐terminal pro B‐type natriuretic peptide levels, 6 min walk distance, comorbidities, renal function, readmissions, mortality, quality of life, and psychosocial characteristics. CONCLUSIONS: The trial seeks to assess whether titration by HF nurses of drugs recommended in practice guidelines is safe and not inferior to direct management by cardiologists. The results could have an impact on clinical practice. John Wiley and Sons Inc. 2017-04-03 /pmc/articles/PMC5695164/ /pubmed/29154427 http://dx.doi.org/10.1002/ehf2.12152 Text en © 2017 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Articles Oyanguren, Juana García‐Garrido, LLuisa Nebot Margalef, Magdalena Lekuona, Iñaki Comin‐Colet, Josep Manito, Nicolás Roure, Julia Ruiz Rodriguez, Pilar Enjuanes, Cristina Latorre, Pedro Torcal Laguna, Jesús García‐Gutiérrez, Susana Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol |
title | Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol |
title_full | Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol |
title_fullStr | Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol |
title_full_unstemmed | Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol |
title_short | Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol |
title_sort | design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. etific study protocol |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695164/ https://www.ncbi.nlm.nih.gov/pubmed/29154427 http://dx.doi.org/10.1002/ehf2.12152 |
work_keys_str_mv | AT oyangurenjuana designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT garciagarridolluisa designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT nebotmargalefmagdalena designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT lekuonainaki designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT comincoletjosep designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT manitonicolas designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT rourejulia designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT ruizrodriguezpilar designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT enjuanescristina designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT latorrepedro designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT torcallagunajesus designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT garciagutierrezsusana designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol AT designofamulticentrerandomizedcontrolledtrialtoassessthesafetyandefficacyofdosetitrationbyspecializednursesinpatientswithheartfailureetificstudyprotocol |